Futures
Hundreds of contracts settled in USDT or BTC
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Futures Kickoff
Get prepared for your futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to experience risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Tainkang: Subsidiary Continues Procurement of Selected National Centralized Procurement Drugs in Some Medications
Tian Kang announces that its wholly-owned subsidiary, Shandong Huabo Kaisheng Biotechnology Co., Ltd., participated in the bidding for the continuation procurement of drugs whose agreements have expired, organized by the National Organization Collective Procurement Office. According to the “Notice on the Announcement of the Selected Results for the Continuation Procurement of Drugs with Expired Agreements under the National Organization Collective Procurement (LC-YPJX-2026-1),” Huabo Kaisheng’s some drugs were selected for this continuation procurement.